Ryan Steelberg bought $127k of VERI
PRESIDENT AND CEO at Veritone, Inc.. 148,810 shares at an average of $0.85, traded Aug 21, 2026, filed Aug 24, 2026.
Score components
- +25RoleCEO
- +11Trade size$127k at market
- +6Relative to holdingsHoldings up 26%
- +18Price context2% above the 52-week low; 90% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001705446-26-000012, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 21, 2026 | POpen-market purchase Common Stockindirect: The RSS Living Trust, dated April 6, 2012 | +148,810 | $0.85 | $127k | 730,284 | Aug 24, 2026 |
Related signals
Other insiders at Veritone, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 60Notable | VERIsell Veritone, Inc. | Chad Steelberg director, owner | $1.3M 504,657 shares | -94% | |
| 49Moderate | VERIbuy Veritone, Inc. | Ryan Steelberg President and CEO | $102k 49,752 shares | +30% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.